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Successful xenografting of first trimester
human fetal CNS tissue and retina has been re-
ported in the literature. We wished to test the
feasibility ofusing the anteriorchamber ofthe rat
eye to support the development of more mature
human fetal xenografts. Here we report on the
successful outcome of human brain and retinal
transplants. Adult host rats immunosuppressed
with cyclosporinA accepted these xenografts and
supported their further development. Periodic
examination of the host eyes using a direct oph-
thalmoscope or an ophthalmic slit lamp permit-
ted direct visual monitoring of the health and
growth of the transplants. Histologically it was
possible to identify neuronal, macroglial, and
microglial (macrophage) cell types within the
grafts. Mitotic activity and histogenetic differen-
tiation took place. Blood vessels filled with he-
matic cells were commonly present within the
grafts. The walls of these vessels prevented the
leakage ofhorseradish peroxidase, suggesting the
presence of a functional brain-blood barrier in
the graft. These results indicate that it is possible
to use a small animal model to study normal and
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pathological phenomena on late fetalhuman neu-
ral tissues. Our group has already taken advan-
tage ofthemodel to achieveHIVinfectivity offetal
human brain outside the human body.
INTRODUCTION
The use ofthe anteriorchamber as a transplan-
tation site was first attempted by van Dooremaal
/1/, who in 1873 described experiments in which
the rabbit anterior chamber was used to lodge
cells from human labial mucosa and other rather
unlikely explants. This technique preceded the
advent of tissue culture methods and later served
as an adjunct to other means of observing growth
of explanted cells and tissues in an isolated setting
/2/. Subsequent studies utilized explanted fetal
retina in the study of retinal plasticity in this im-
mune privileged site and found allo- and xeno-
transplantation to be quite feasible/2-7/.
In addition, extensive research has been con-
ducted in the area of syngeneic and xenogeneic
grafting of CNS tissue, especially in the study of
mechanisms of human brain development/8-11/.
Olson et al. grafted several areas of 8-11 week
gestation human fetal brain and spinal cord into
the anterior chamber ofnude mice, nude rats, and
rats immunosuppressed with cydospodn A/8/.
Under these conditions, first trimesterhuman eer-
ebellar and cerebral cortex, and hippocampus and
spinal cord xenografts appear to develop histolog-
ically according to a human time-table/9-11/.
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Among the objectives of our laboratories are to
develop animal models for viral infections of
human neural tissue and to obtain functional ret-
inal transplants. To achieve these objectives, the
use of late, more mature, fetal tissue is desirable.
Herein we describe successful xenografts of sec-
ond trimester human brain and retinal tissue into
the rat anterior chamber.
METHODS
Host animals
The hosts for this study were 100-120 day old
male Sprague-Dawley rats (Charles-River) of
200-350 gram body weight that were pathogen
flee. The animals were housed in sterilized
microisolator cages in a cubicle used for these
studies only. They were maintained on an im-
munosuppressive regime utilizing cyclosporin A.
We determined that optimal results were ob-
tained with a dose of6 mg/kg i.m. one day prior to
transplantation, followed by a maintenance dose
of 5.0-6.0 mg/kg i.m. daily, adjusting the dose ac-
cording to blood levels and serial weights. This
resulted in cyclosporin A blood levels of 1000-
1500 ng/ml using both monoclonal and polyclonal
antibody detection assays.
Donor tissues
Procurement offetal tissues from elective ther-
apeutic abortions was in ’strict accordance with
scientific and ethicalguidelines oftheNIH andthe
University of Rochester. Consent for the use of
fetal tissues in researchwas obtained by the obste-
trician from the mother, although specific re-
search projects were not des.ignated. The tissue
used could not be identified by name, hence con-
fidentiality was assured.
Aftervacuum extraction, the gestational age of
the tissue was confirmed, using heel-to-toe mea-
surements in comparison with standardized
charts. Brain or retinal tissue from fetuses be-
tween 12 and 19 weeks gestation was used for
these studies. The number of animals that re-
ceived transplanted tissue at each gestational age
were distributed as follows: 12 weeks gestation
(n 24), 13 weeks gestation (n 9), 14 weeks ges-
tation (n= 11), 15 weeks gestation (n=7), 17
weeks gestation (n 16), and 19 weeks gestation
(n= 10).
Large fragments of neural tissue were identi-
fied and collected in human plasma. The intact
retina or brain regions of interest were separated
under a dissecting microscope with the tissue sub-
merged in flesh human plasma and mechanically
dissociated into small (<0.5 mm3) fragments
using curved iris scissors. The brain region rou-
tinely used was telencephalon, including both the
ventricular and cortical surfaces, which includes
proliferating neuronal and glial precursors (Fig.
1).
Surgical procedure
Small fragments of human fetal brain tissue
were backloaded into a 50 ,ul Hamilton syringe.
Following general and topical anesthesia, 101 of
fetal tissue suspension was injected into the ante-
rior chamber via a 27 gauge butterfly needle using
direct observation under the dissecting micro-
scope. Excess fluid was allowed to egress by par-
tial removal ofthe injecting needle. The puncture
sites were clean and self-sealing.
The progress of the transplants and the status
of the eyes’ anterior chambers were periodically
monitored through the transparent cornea using
direct ophthalmoscopy or under a stereomicro-
scope or slit lamp with photographs taken as nec-
essary. All surgical procedures were carried out
in accordance with the NIH Guide for the Care
and Use of Animals in Research.
Histological and immunohistochemical studies
Animals were anesthetized with a lethal dose
of pentobarbital at selected intervals after trans-
plantation ranging from 2 to 35 days. Following
enucleation, each eye containing a xenograft was
fixed in either 4% paraformaldehyde for 2 hours
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Light micrograph of 14.5 gestational weeks human telencephalon. The sample contains a cluster of subventricular cells, some of which are
undergoing mitosis (arrowheads), the rest of the tissue is formed by more mature neural cells and an extensive neuropil.
Macrophotograph of a rat eye bearing a 14.5 weeks gestational age human retinal xenograft 30 days post-transplantation. The graft has
developed into two masses of tissue (arrows), one peripheral and one more centrally located. The central mass is connected to the dilated
pupillary border by a thin tissue strand.
Light micrograph of the retinal xenograft illustrated in Fig. 2. At 60 post-transplantation days, the graft has grown and differentiated into
multiple rosettes (R). The photoreceptor cells forming the rosettes project immature inner segments into the lumina.
Electron micrograph of the luminal surface of a rosette formed by a 14.5 week human retina. The closely packed immature photoreceptor
cells have formed junctional complexes in their apical portions (arrows) similar to those present in the normal outer limiting membrane of
the normal retina.
Light micrograph of a section of 14.5 weeks gestational age human telencephalon reacted with an antibody to the neuronal marker PGP
9.5. At 7 post-transplantational days, numerous cell bodies and slender processes show a positive reaction.
Light micrograph of the same explant as in Fig. 5 but reacted with antibody to the astroglial marker GFAP. A number of cells scattered
throughout the tissue show positive reaction. In addition, there is a fine band of positive reacted cytoplasm around a small blood vessel (V).
An arrowhead points to a stained cytoplasmic process abutting onto the vascular wall.
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Fig. 7: Electron micrograph depicting an area of neuro-
pil, and part of the body of a neuroblast in the
upper right corner of the picture. A synaptic
contact is indicated by the arrow. The nucleus of
the neuroblast (N) is surrounded by a thin rim of
cytoplasm. Human fetal brain xenograft, 12.5
weeks gestational age. Six days survival time.
49,000x.
Fig. 8: Electron micrograph depicting a growth cone
filled with vesicles and some mitochondria, and
located in the neuropil of the same xenograft as
in Fig. 7. 20,000 x.
Fig. 9: A reactive macrophage (arrow) in the neuropil of
the same specimen depicted in Figs. 7 and 8. The
cell cytoplasm contains numerous secondary
lysosomes. These cells appearto be the counter-
parts of the microglial elements identified under
the light microscope. 5,700 x.
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at 4C for paraffin embedding, or in 2% glutaral-
dehyde in a 0.1 M cacodylate buffer (pH 7.2-7.4)
for plastic embedding, lmmunohistochemical
studies were performed with avidin-biotin kits
(Vector ABC) using modifications of the proce-
dure of Hse et al./12/. Primary antibodies used
included anti-glial fibrillary acidic protein (bovine
GFAP, DACO), and anti-PGP 9.5 (Ultraclone
Limited)/13/to identify astrocytes and neurons
respectively. Biotinylated lectinRicinnuscommu-
n/s Agglutinin-1 (RCA-l-lectin, Vector)/14/,was
used to identify microglia.
Horseradish peroxidase marker studies
To test whether vascularized xenografts de-
velop an intact blood-brain barrier, two rats with
xenografts established two weeks earlier were in-
jected via the femoral vein with horseradish per-
oxidase (HRP, Sigma Type VI, 25/g/100 g body
weight) with minor modifications of the protocol
ofHirano/15/. After 30 minutes, the animalswere
perfused with2% paraformaldehyde/2% glutaral-
dehyde in a 0.1M cacodylate buffer (pH 7.2-7.4).
Tissue sections were treated with H202 and
diamino-benzidine to expose the peroxidase
marker, and prepared for ultrastructural examina-
tion as previously reported/2/.
RESULTS
Xenograft survival
The overall success rate in establishing viable
xenografts into rat eyes was 82% (63/77). A suc-
cessful xenograft was defined as such by the pres-
ence of a healthy appearing graft at one week
post-transplantation. In all cases enucleationwas
performed while the animals harbored healthy
transplants. The longest survival was 60 days.
However, in many experiments, the animals were
killed prior to this point to assess histogenetic
development of the transplant. Grafts placed in
animals without immunosuppression regressed
after seven to ten days.
Bi-weekly ophthalmological examination re-
vealed that healthy neural tissue grafts enlarged to
form spherical or oblong masses, 1 to 2.5 mm in
size, with well defined limits and a characteristic
pearlish white glow present on the surfaces (Fig.
2).
Light and electron microscopical observations
Light microscopical study of plastic embedded
sections from grafted eyes confirmed and ex-
panded the in vivo observations. Almost invari-
ably the grafts grew attached to either the anterior
iridal or the posterior corneal surfaces, with some
larger grafts bridging both structures. Blood ves-
sels were seen frequently. They appeared to be
vascular outgrowths linking the graft to the host
iridal vessels. The growth process continued
within the grafts, as evidenced by the definite
increase in total mass as well as by the presence of
mitotic cells. The brain tissue grafts showed neu-
roblasts characterized by finely dispersed nuclear
chromatin, one or two prominent nucleoli, and
some cytoplasmic processes arising from the cell
soma. A meshwork of these processes formed a
neuropil separating neuronal cells from each
other. Retinal grafts (Figs. 3 and 4) were charac-
terized by the presence of conspicuous photo-
receptor rosettes, with relatively large central
lumina. Neural cells reminiscent of those in the
inner nuclear layer of the normal retina were ar-
ranged outside the rosettes. Immunohistochemi-
cal studies identified PGP 9.5 positive neurons
(Fig. 5) and GFAP positive astroglia (Fig. 6); also
a few RCA-1 positive "microglia" cells were seen.
It was usual to find an absence of inflammatory
cells in the host anterior chamber, a finding in
agreement with the clear ocular media observed
during the in vivo examinations.
Electron microscopical analysis of the grafts
revealed the presence of synaptic contacts (Fig. 7)
and growth cones/16/(Fig. 8). Presence of the
latter offers a further suggestion thatneurogenesis
continues with the grafts. Ultrastructural identifi-
cation of neuroblasts, or young neurons, with
relatively large nuclei and scant cytoplasm was
possible at this level (Fig. 7). Although astroglial
cells and a discontinuous glial ensheathment of
the blood vessels were seenunder the light micro-
scope, unambiguous identification of astroglial
cell bodies was not possible. In contrast it was
possible to identify the electron microscopical
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correlates of active microglial cells in the form of
macrophages containing abundam secondary
lysosomes in their cytoplasm (Fig. 9).
Studies of the blood-graft barrier
After the injection of horseradish peroxidase,
the tracer penetrated other tissues but not the
vascularized xenograft, suggesting that a func-
tional blood-brain barrier was formed within the
transplanted human neural tissue (data not
shown).
DISCUSSION
We have demonstrated that second trimester
human fetal brain explants (12-19 weeks gesta-
tion) can survive in the anterior chamber of adult
immunosuppressed rats. Other investigators have
studied xenografts of first-trimester human CNS
/8-11/and retina, sometimes with post-transplan-
tation survivals as long as 200 days/17/. However,
little has been reported on transplantation of
olderhuman fetal neural tissue, and the consensus
has been that these older explants fail to thrive.
Further studies are needed to determine the rea-
sons behind the successful outcome of our grafts.
Nonetheless, it is ofinterest to compare the results
obtained and to discuss the opportunities offered
by explants of different gestational ages.
The first issue emerging from comparisons be-
tween the fate of first versus second trimester
xenografts deals with tissue survival. The evi-
dence available suggests that the general rule in
neural transplantation that earlier fetal material
fares better than its more developed counterparts
may not be without exceptions. Comparison be-
tween the outcome ofCNS xenografts ofdifferent
ages, performed by different investigators, are
hampered by possible variations in sample selec-
tion and handling. In the case of retinal grafts,
however, it is possible to make closer correlations
since the experimental differences tend to be nar-
rower. Here the survival ofsecond trimester sam-
ples appears to be at least as good as that seenwith
first trimester. Aramant et al. report survival of28
out of52 grafts, and only 6 of those survivingwere
deemed appropriate for extensive histological
evaluation/17/. Our retinal series has survived at
a better rate, not only in the anterior chamber as
reported here, but also in the subretinal space (del
Cerro et al., in preparation). A factor here maybe
the need for shorter survivals required to obtain
similar maturational stages when the explant is
obtained at a more advanced gestational age. An
example of the ability to use shorter survivals is in
the study of synaptic development and photo-
receptor formation in retinal human xenografts,
since these developmental events take place dur-
ing mid-gestation/18/. A shorter host survival, in
turn, represents an abbreviated exposure of the
graft to possible deleterious effects of the im-
munosuppressive regimen. Both Aramant et al.
and we have resorted to cyclosporinA treatment
to prevent rejection of the xenografts. However,
we have found that close monitoring of blood
cyclosporin levels is essential to define the narrow
gap between the induction of cyclosporin toxicity
in the host on one hand, and insufficient im-
munosuppression leading to graft demise on the
other. Prolonged survival of these xenografts re-
quired blood cyclosporinA levels in the range of
1000-1500 ng/ml, a level higher than previously
suggested/19/. Bickford-Wimer et al. showed im-
proved brain explant survivability in athymic nude
rats over rats immunosuppressedwith cyclosporin
A/10/. It may be that the higher levels achieved
via the parenteral route, with concomitant evi-
dence of toxicity through close monitoring of
cyclosporin A levels, allowed for better im-
munosuppression. A less than optimal host envi-
ronmentunder these conditionsmay be one ofthe
reasons for Aramant’s et al.’s observation that in
their series, grafts of the same total age (i.e., ges-
tational age plus survival time) showed dissimilar
maturation development. Furthermore, brain re-
gions are more accurately identifiable when ob-
tained from older specimens, and fetal tissue of
ages 12-18 weeks are those most generally avail-
able for research. Finally, we expect to examine
the issue of vulnerability of fetal brain to a viral
infectionwhich may occur only at late time points
during gestation.
Study of the humanCNS has always been diffi-
cultdue to its inaccessibility. Studies oftheviruses
with tropism for the human CNS have been lim-
ited by the lack of a model in which intact human
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neural tissue can be exposed to infectious virus,
virus infected cells, or putative neurotoxic factors.
Human immunodeficiency virus type 1 (HIV-1) in
particular, is highly species specific, and is known
to exhibit important biological differences when
studied in vitro as compared to in vivo /20/. HIV-1
invades the CNS of children and adults and is
thought to be responsible for the progressive en-
cephalopathy/21, 22/, and for the underlying neu-
ropathological changes observed in children with
AIDS/23/. Transplantation ofhuman CNS tissue
into a small animal provides an excellent system
inwhich to study normal developmem and patho-
logical conditions. In addition, use ofthe anterior
chamber offers aunique advantage in that survival
and growth of the xenograft can be visually moni-
tored without invasive procedures. Preliminary
studies using this model have demonstrated that
the grafts can be infected with cell free virus and
HIV-1 laden macrophages/24/. Future investiga-
tions using these xenografts shouldprove useful in
elucidating the pathogenesis of CNS infection
with HIV-1 and other neurotropic viruses, partic-
ularly in the developing nervous system. Further-
more, this model may have a broader application
forthe screening ofantiviral and othertherapeutic
agents which target the CNS.
A corollary of the previous discussion is that
second-trimester xenografts in the anterior cham-
ber may prove to be the optimal model for the
study of anatomical, physiological, and pathologi-
cal phenomena associated with more advanced
human gestation stages.
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